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Abstract: Elucidating the origin of enzymatic catalysis stands as one the great challenges 
of contemporary biochemistry and biophysics. The recent emergence of computational 
enzymology has enhanced our atomistic-level description of biocatalysis as well the  
kinetic and thermodynamic properties of their mechanisms. There exists a diversity of 
computational methods allowing the investigation of specific enzymatic properties. Small 
or large density functional theory models allow the comparison of a plethora of 
mechanistic reactive species and divergent catalytic pathways. Molecular docking can 
model different substrate conformations embedded within enzyme active sites and 
determine those with optimal binding affinities. Molecular dynamics simulations provide 
insights into the dynamics and roles of active site components as well as the interactions 
between substrate and enzymes. Hybrid quantum mechanical/molecular mechanical 
(QM/MM) can model reactions in active sites while considering steric and electrostatic 
contributions provided by the surrounding environment. Using previous studies done 
within our group, on OvoA, EgtB, ThrRS, LuxS and MsrA enzymatic systems, we will 
review how these methods can be used either independently or cooperatively to get insights 
into enzymatic catalysis. 
Keywords: enzyme catalysis; density functional theory (DFT) cluster method;  
quantum mechanics/molecular mechanics (QM/MM); molecular dynamics (MD) simulations; 
molecular docking 
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1. Introduction 
Enzymes, being essential to life, have long been the focus of considerable efforts, in order to 
understand their properties and biochemical roles. In addition to the fundamental chemical insights to 
be gained, it may also lead to the development of new therapeutic drugs and synthetic catalytic  
systems [1–3]. Central to a complete understanding of an enzyme is the elucidation of its catalytic 
mechanism. Numerous investigations have ascribed the origin of enzymes rate-enhancing power to 
several possible factors including steric effects and transition-state stabilization [4]. Unfortunately, the 
precise driving forces and atomistic-level details underlying many mechanisms remain unknown or are 
the subject of considerable discussion and, at times, controversy [5–7]. Various “models” have been 
developed to explain their machinery: some have focused on the possible role of the overall structure 
and corresponding conformational variations [8–10], while others have focused on the role of a few 
chemical species and functional groups within their active sites [11–13]. Collectively this has led to  
the gradual development of a more holistic picture of enzymatic catalysis. That is, enzymes are 
increasingly seen as systems that must be considered both at atomistic and macroscopic levels. 
1.1. Experimental and Computational Enzymology 
Experimental biochemists routinely use a wide variety of techniques and methods to study the 
structure, reactivity and dynamics of enzymes and their corresponding biochemical processes. Indeed, 
methods such as X-ray crystallography, mutagenesis, kinetic isotope studies, mass spectrometry,  
and ultraviolet-visible, fluorescence, infrared, circular dichroism and nuclear magnetic resonance 
spectroscopies can each provide insights into the system under study. 
Key aspects of enzymatic processes can be acquired through the complementary application of 
experimental and theoretical methodologies. Indeed, the shortcomings of one can often serves as the 
strengths of the other. For example, as one of the limitations of experimental methods is their inability 
to directly characterize transition states and reactive intermediates constitutes, one can often rely on 
computational methods to model the different species along the reaction pathway. Furthermore, 
experimental methods, which provide extensive mechanistic insights, often constitute the pillars of 
computational studies in addition to serving as benchmark for the validation and development of 
computational methods. 
Due to the complexity of enzymatic systems, many computational models are derived from  
X-ray crystal structures. As the latter represents a powerful tool that provides detailed insights into the 
3D structure of an enzymatic system, the resulting structures are often successfully used to infer 
reaction steps or entire mechanisms. In conjunction with crystal structures, computational methods can 
model the dynamic properties of enzyme and their ability to undergo conformational changes. 
Furthermore, as crystal structures do not always correspond to enzymes’ endogenous state, 
computational methods can be used to remedy the effect of crystallization by solvating the enzyme, 
and through simulated annealing, remove lattice-packing effects. Since these effects may result in 
misleading inferences [14–18], the synergetic use of crystallography and computational studies 
presents itself as a valuable tool in enzymology. 
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1.2. Computational Enzymology Methods 
Recent years have seen the emergence of computational chemistry methods in the fields of 
enzymology. This has been facilitated by the development of methods that collectively span a broad 
range of computational approximations and chemical models such as: (i) docking; (ii) molecular 
dynamics (MD) simulations; (iii) quantum mechanical-chemical cluster (QM-cluster); and (iv) hybrid 
quantum mechanics/molecular mechanics (QM/MM) methods. Consequently, whether these methods 
have been used to study enzymes at the quantum mechanical level (while investigating orbital steering 
and tunneling effects) [19,20] at an intermediate level (while looking at the different substrate 
conformations inside active sites) [17] or at the macroscopic scale (where domain motions and 
conformational transitions could potentially play rate-limiting roles in enzyme catalysis) [21], they 
have become indispensible tools in the study of biomolecules. Many excellent books and reviews have 
previously described some of the computational methods that are commonly employed in multi-scale 
computational investigations, and listed above. Hence, only a brief overview is provided herein with an 
emphasis on their possible application to enzymology. 
As noted above, X-ray crystallographic structures do not always possess the “natural” substrate(s) 
bound to the enzyme’s binding site(s). In some cases, receptor bound inhibitors or substrate-analogues 
were used to investigate substrate-receptor interactions. In other cases, the complete absence of 
substrate or substrate-analogues in available crystal structures prohibits the deduction of these 
interactions. In such instances, molecular docking methods can be used to model sets of probable 
“natural” substrate binding modes with scoring algorithms providing some measure of the preference 
of the resulting complexes [22]. 
Molecular dynamics (MD) simulations enable one to model the time-dependent trajectories of 
atoms within a system. Such methods require atomic accelerations to be computed and combined with 
the positions and velocities at a given time t to calculate new positions and velocities at time t + δt. 
During each time-step, forces are assumed to be constant but must be recalculated for each time step. 
Molecular mechanics (MM) forcefields are typically used to describe the atoms or groups within the 
chemical system. Although such methods cannot be used to investigate “electronic” processes such as 
bond making and breaking, they enable sampling of the configuration space thereby allowing one to 
explore and consider multiple points on the potential energy surface. Furthermore, very extensive 
chemical systems such as solvated enzyme···substrate complexes can be modeled in their entirety.  
In addition, one can incorporate pressure, temperature and volume effects in a time dependent manner. 
Thus, for example, one can use such methods to obtain average structures of solvated, thermally 
relaxed (at 298 K) enzyme-substrate complexes [23]. 
In a quantum mechanical-cluster approach [24] a small to modest sized (e.g., ≤200 atoms) chemical 
model of the complete enzymatic system is used. Typically, such a model is derived from crystal 
structures, although this is not an absolute requirement (see below). The model generally includes the 
substrate, its reactive component and key active site residues that are either mechanistically important 
or interact with the substrate. In the case of metalloenzymes, where a substantial part of the catalysis is 
often determined by the electronic properties of the metal ion, a valid model should contain the metal 
as well as its immediate coordination environment [25–27]. A select few atom centers, at a remote 
region from the reactive region, are held fixed in order to maintain the integrity of the chemical model. 
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The cluster can be further complemented by modeling the rest of the surrounding enzyme via a 
polarizable continuum (PCM) solvation method. With regards to the choice of QM method, due to 
their computational speed and ability to provide reliable results, the vast majority of QM-cluster 
studies use density functional theory (DFT) methods (e.g., B3LYP) [28]. The resulting approach can 
model reactants, intermediates, transition states and product complexes, providing insights into their 
electronic, kinetic and thermodynamic attributes. 
Hybrid QM/MM methods can be applied to extensively large chemical models as they partition 
them into several sub-systems (layers), which can then be treated at different levels of theory. 
Typically, the model is divided into two layers with the high-layer containing the enzyme’s reactive 
region and the second, low-layer containing the surrounding protein and environment. The QM/MM 
formalism can in principle utilize a diverse combination of methods. In practice, however, the  
high-layer is commonly described using a DFT method (although it should be stated that  
semi-empirical methods have been extensively used especially in QM/MM-MD) while the low-layer is 
described by an MM forcefield such as AMBER [29–32], CHARMM [33–35], GROMOS [36–38] or 
OPLS-AA [39–41]. The latter methods have been parameterized specifically for biochemical systems 
such as proteins and nucleic acid complexes. The energy of the total system can be partitioned in two 
ways through either an additive (QMMM) [42–44] or subtractive (ONIOM) [45] scheme as seen in 
Equations (1) and (2), respectively. 
ܧ୘୭୲୕୑/୑୑ = ܧୖ୉୕୑ + ܧୗ୉୑୑ + ܧୖ୉∩ୗ୉୕୑∩୑୑ (1)
ܧ୘୭୲୓୒୍୓୑ = ܧ୘୭୲୑୑ − ܧୖ୉୑୑ + ܧୖ୉୕୑ (2)
The additive scheme requires a QM calculation on the reactive environment ൫ܧୖ୉୕୑൯ , an MM 
calculation on the surrounding environment ൫ܧୗ୉୑୑൯ followed by an energy coupling representing the 
interaction between the QM and MM layers ൫ܧୖ୉∩ୗ୉୕୑∩୑୑൯. In contrast, the subtractive scheme as used in 
ONIOM requires an MM calculation on the entire system ൫ܧ୘୭୲୑୑൯  and both an MM ൫ܧୖ୉୑୑൯	and  
QM ൫ܧୖ୉୕୑൯ calculation on the reactive environment. Thus, QM/MM methods couple the speed of  
MM methods with the ability of QM methods to model chemical reactions. Furthermore, they enable 
one to better model the non-homogeneous environment around the active site. 
While powerful, each computational method suffers from inherent limitations. Although progress in 
computational software has allowed them to become increasingly user friendly and widespread, they 
should not be used in a “black-box” matter. For instance, common scoring functions often do not 
correlate with experimental binding affinities. Furthermore, limitations in search algorithms and 
scoring functions renders only 60% of docking results as reasonable [46]. Classical molecular dynamic 
simulations are often poorly equipped for certain systems (such as transition metals) and simulate 
time-scales that are often too short to appropriately model key biological processes (such as substrate 
binding) [47]. A QM-cluster approach can at times inaccurately model entropic and solvation effects. 
The former allows the calculation of the free energy surface, which unlike the potential energy surface, 
corresponds to macroscopic observables [48]. Furthermore, QM-clusters cannot model the inherent 
polarization present in enzymatic systems, which are often key to their enzymatic mechanisms. Such 
limitations are to be considered in addition to those related to a lack of electron correlation for each 
QM method. Amongst the diverse shortcomings of QM/MM methods, the misrepresentation of the 
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QM/MM boundaries and the interactions between the two layers are noteworthy examples [49]. 
Certainly, experimental methods can be used to assess and enhance the performance of computational 
techniques and even inspire their development. 
In this review, several examples of a multi-scale approach to computational enzymology are 
presented. This review comes at a fortunate time since shortly prior to its publication, the 2013  
Nobel Prize in chemistry was awarded to Karplus, Levitt and Warshel “for the development of  
multi-scale models for complex chemical systems” [50]. It is also noted that an increasing number of 
studies can be found in the literature that also provide wonderful examples of the enhanced 
understanding arising from and the capabilities of employing such a computational approach. For the 
purposes of this review, however, examples are presented from our own work and namely will focus 
on the synergistic application of two or more methods within the areas of docking, MD, QM-cluster 
and ONIOM (QM/MM) to investigating biocatalysis. 
2. Computational Enzymatic Studies 
2.1. OvoA and EgtB: Characterizing Potential Mechanistic Oxidants 
5-Histidylcysteine sulfoxide synthase (OvoA) and 2-histidyl-γ-glutamyl cysteine sulfoxide  
synthase (EgtB) activate dioxygen and react it with histidine and cysteine derivatives to synthesize  
sulfur-containing antioxidants. Although no X-ray crystal or NMR structures are available, some 
features related to their structure and activities have been experimentally deduced or determined.  
In particular, in both enzymes an iron is ligated to two histidyl imidazoles and a carboxylate  
side-chain. Because of their common chemistry and similar structural features, it has been suggested 
that they share similar catalytic mechanisms [51]. 
In particular, the mechanism of OvoA has been proposed to occur in four steps (Scheme 1) [52]. 
First, cysteine and O2 binds to the Fe(II) center to give an Fe(III)O2·− containing complex. The 
Fe(III)O2·− then attacks the ligated cysteine while undergoing homolytic O–O bond cleavage to form a 
sulfoxide···Fe(IV)=O complex. In the subsequent step, the latter complex oxidizes the co-substrate 
histidine’s imidazole via abstraction of a H· from either from the histidyl’s Cδ–H, forming a  
C-centered radical, or Nδ–H to give a π-delocalized radical [52]. In the fourth and final step, the 
imidazole radical attacks the sulfoxide, forming a histidyl-cysteinyl sulfoxide derivative. Intriguingly, 
it is unclear why a sulfoxide intermediate is formed but may be related to the need to form the 
powerful Fe(IV)=O oxidant in order to oxidize the histidine co-substrate’s imidazole R-group. 
As noted above, no experimental X-ray crystal or NMR structures are available of OvoA. Hence, 
we chose to use of a QM-cluster based approach to investigate possible Fe-coordination environments 
and importantly, their impact on the redox potentials of mechanistically relevant intermediates [53]. 
The chemical model included the Fe ion, the R-groups of the residues to which it is ligated, as well as 
the three cosubstrates; O2, the imidazole of histidine, and cysteine. The surrounding protein 
environment was included via use of an integral equation formalism (IEF-PCM) [54] solvation model 
with a dielectric constant of 4.0. The entire model and free energies were then described at the  
IEF-PCM-B3LYP/6-311G(2df,p)//B3LYP/6-31G(d) + ΔGcor level of theory, where ΔGcor corresponds 
to the Gibbs free energy corrections added to electronic energies and obtained via vibrational 
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frequency calculations. In total, due in part to the number of possible coordination models and  
spin-states (multiplicities), 196 possible active site model complexes were examined. 
Scheme 1. Schematic representation of the experimentally proposed mechanism for 
biosynthesis of a histidyl-sulfoxide derivative (adapted from [53]). 
 
First, the oxidation of imidazole (a model of the mechanistically relevant component of the histidine 
co-substrate) was considered. This can potentially occur via one of three pathways: (i) an  
electron transfer (ET); or a proton-coupled electron transfer (PCET) from either a (ii) imidazole 
nitrogen (i.e., Nδ–H) or (iii) carbon (i.e., Cδ–H). Specifically, the free energy in a SHE reference state 
for each process was calculated via a first principle quantum statistical mechanical approach [53]. 
Oxidation of imidazole via an ET process corresponds to an increase in 186.0 kJ mol−1 in free energy 
and hence is non-spontaneous. Similarly, H· abstraction from the Cδ–H or Nδ–H moieties of an 
imidazole via a PCET process corresponded to an increase in 250.1 and 171.0 kJ mol−1 in free energy, 
respectively. Thus, oxidation of imidazole would appear to preferably proceed via a PCET process 
involving H· abstraction from the imidazole’s Nδ–H group. Importantly, its required energy can now 
help provide insights into the mechanistic feasibility of a particular oxidant complex (see below). 
Experimentally, three of the ligands to the Fe centre were concluded to be the R-groups of two 
histidyl’s and a glutamate while a fourth ligand is oxygen or O2. However, it is unclear if the cysteine 
binds mono- or bidentately to the Fe centre. Hence, a series of active site-inspired oxidant complexes 
were generated, which in some cases had water as a sixth ligand. The resulting complexes, which in 
total numbered 196, could be classified as belonging to one of three “model sets” depending on 
whether they contained an: (A) Fe(III)O2·−; (B) sulfoxide···Fe(IV)=O; or (C) Fe–OO–SCys crosslink 
moiety (Scheme 2). The free energy of their reduction via ET and PCET was then calculated for  
each complex. 
First, the possible spin-states of each initial complex were examined within the QM-cluster 
approach. For all sets of models the preferred ground state of the initial non-reduced metal system was 
a septet spin-state. For the reduced systems, however, those obtained via an ET process preferred a 
quartet and sextet ground spin-states (depending on the particular complex) while all systems obtained 
via a PCET process preferred a quartet ground spin-state. 
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Scheme 2. Schematic representation of the mechanistic oxidant complexes considered: 
those containing a (A) Fe(III)O2·−; (B) sulfoxide···Fe(IV)=O; or (C) Fe–OO–SCys  
crosslink moiety. 
 
For model Set A, complexes reduction via an ET process was revealed to be endergonic by at least 
60.4 kJ mol−1 and hence, non-spontaneous. On the other hand, reduction via a PCET process was 
exergonic with calculated free energies ranging from −55.6 to −84.7 kJ mol−1. Thus, while their 
reduction via PCET is favorable, it is still significantly lower than the inherent energy required to 
oxidize a histidine’s R-group imidazole. That is, the mechanistic oxidant in OvoA is unlikely to 
correspond to an active site containing an Fe(III)O2·− moiety. 
The previously experimentally proposed mechanistic oxidant is an Fe(IV)=O type complex [52].  
As noted above, a range of models of possible sulfoxide···Fe(IV)=O containing active site  
complexes (i.e., Set B) were considered, as well as their reduction via an ET or PCET process. Similar 
to Set A, reduction of any of the Set B complexes via an ET process was calculated to be endergonic, 
though now by at least 44.4 kJ mol−1. Again, this indicates that such a reduction process is inherently 
unfavorable. In contrast, reduction via a PCET process was calculated to be thermodynamically very 
favorable with free energies ranging from −114.1 to −146.5 kJ mol−1. That is, active sites containing an 
sulfoxide···Fe(IV)=O moiety are inherently more oxidizing than the Fe(III)O2·− containing  
complexes (Set A). However, as observed for the Set A species, their oxidizing potentials are still not 
inherently sufficient to oxidize the histidine co-substrate’s side chain imidazole. 
Complexes containing an Fe–OO–SCys moiety (Set C) had not previously been considered in the 
proposed mechanism for OvoA and EgtB, but had been investigated computationally in  
cysteine dioxygenase (CDO) [55]. Unlike the complexes of Sets A and B, reduction of Set C 
complexes via an ET process resulted in mechanistically infeasible complexes. In contrast, their 
reduction via a PCET process was found to be significantly exergonic and thus favorable with free 
energies ranging from −203.9 to −268.3 kJ mol−1. In fact, Fe–OO–SCys containing complexes within 
Set C have sufficient oxidizing power to overcome the inherent energy required to oxidize the histidine 
co-substrates imidazole via PCET; i.e., effectively abstracting a H· from the imidazole’s Nδ–H or  
Cδ–H moieties. However, these results do more than affirm that a Fe–OO–SCys intermediate may be the 
required mechanistic oxidant in the enzymes OvoA and EgtB. They also provide invaluable 
mechanistic insights including the possible reason for formation of a sulfoxide intermediate; it is a 
result of reducting of a Fe–OO–SCys intermediate. 
From the QM-cluster study a possible mechanistic pathway for OvoA and EgtB can be suggested 
and is shown in Scheme 3. 
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Scheme 3. Schematic representation of computationally proposed intermediates in the 
formation of histidyl-sulfoxide (adapted from [53]). 
 
As described above, even in the absence of a crystal structure a large amount of chemical and 
mechanistic insight can be gained via a well-chosen QM-cluster approach. In this specific case, such a 
method was used in conjunction with a first principles quantum statistical mechanical approach for redox 
properties. Significantly, while the present results do not conclusively elucidate the mechanisms of OvoA 
and EgtB, they provide insights into their catalytic mechanisms and active sites. In addition, however, they 
also give broad and applicable fundamental insights into the reduction of imidazole and importantly, 
the effects of a Fe centre’s coordination environment on particular Fe-complexes’ redox properties. 
2.2. Threonyl-tRNA Synthetase (ThrRS): Identifying a Mechanistic Base? 
Aminoacyl-tRNA synthetases (aaRS’s) are a ubiquitous class of enzymes. They are perhaps best 
known for their central role in protein synthesis. Specifically, they catalyze the aminoacylation of their 
cognate tRNA [56–59] via the two half reactions shown in Scheme 4 [59–61]. First, the amino acid is 
activated by reacting with ATP to give an aminoacyladenylate (aaAMP). Then, within the same active 
site, they catalyze the transfer of the aminoacyl moiety of aaAMP onto the 2'- or 3'-oxygen of the 
Ado76 residue of the cognate tRNA (tRNAaa). 
In the second half reaction, the ribose oxygen of Ado76 nucleophilically attacks the carbonyl 
carbon of the aminoacyl moiety. However, first, a suitable base must activate the oxygen. In fact, 
aaRS’s active sites have been observed to generally lack such residues [61–63]. Hence, it has been 
thought that aaRS’s may use a substrate assisted mechanism wherein one of the substrate’s own  
non-bridging phosphate oxygens (the pro-R/S oxygens) acts as the missing catalytic base [61]. 
Recently, Francklyn and coworkers examined threonyl-tRNA synthetase catalyzed aminoacylation [63]. 
In particular, their mutagenesis studies indicated that replacing the pro-S or -R oxygens by sulfur had 
little effect indicating that they were not catalytically essential [63]. On the other hand, mutation of the 
active site histidyl (His309) caused a more significant decrease in the rate of reaction. Hence, it was 
proposed that His309 directly or non-directly (via a water molecule) deprotonates the Ado76-2'-OH 
moiety of the cognate tRNA. The resulting 2'-O− then deprotonates the adjacent Ado76-3'-OH group, 
thereby enabling the 3'-oxygen to better act as a nucleophile [63,64]. 
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Scheme 4. General overall mechanism of (i) amino acid activation and subsequent  
(ii) aminoacylation of the cognate tRNA catalyzed by aminoacyl-tRNA synthetases. 
 
Recently, we have used several computational methods such as MD and QM-cluster approach in a 
complementary fashion to elucidate the nature of the active site base in the second half reaction of 
theronyl-tRNA [59,62]. Unfortunately, while several X-ray structures are available for ThrRS, none 
have both ThrAMP and tRNAThr bound [62]. Therefore, we began by modifying an available X-ray 
structure of ThrRS···(tRNAThr + AMP) (PDB code: 1QF6 [65]) to include the threonyl moiety [53]. 
The latter’s positioning was verified by comparing to other available X-ray crystal structures. 
Although His309 has initially been proposed to act as a catalytic base, for completeness and because 
its pKa is close to 7, we have also considered the use of a protonated His309 in which it could act as an 
acid. MD simulations were performed on all four complexes in order to examine their fully-bound 
active site structures and the consistency of the catalytically relevant interactions. Analysis of atomic 
trajectories indicated that in both neutral and protonated His309 (His309-H+), the addition of a water 
bridge between His309 and Ado76-2'-OH negatively impacted the substrate positioning and the 
consistency of key mechanistic interactions. In contrast, when no additional water was added, for both 
neutral and protonated His309, the tRNAThr and ThrAMP substrates were better positioned for 
reaction, and important active site interactions were significantly more consistent. 
Although previous MD simulations provided some useful insights into the possible roles of the 
active site residues, it cannot be used alone to elucidate the mechanism. Subsequently, for both neutral 
and protonated His309 without a “bridging H2O”, we obtained suitable chemical models for use in a  
QM-cluster study on the catalytic aminoacylation mechanism of ThrRS [58]. Specifically, the 
chemical cluster included the active site Zn(II) and R-groups of its first coordination sphere ligands 
His511, His385 and Cys334. In addition, the residue R-groups of His309, Asp383, Gln381, Arg363 
and Lys465 were also included while the ThrAMP and tRNAThr substrates were modeled by  
methyl monophosphate threonyl and 1',5'-deoxyribose, respectively [58]. The surrounding protein 
environment was modeled using a PCM method with a dielectric constant of 4.0. Relative energies 
were obtained at the IEF-PCM(ε = 4.0)-B3LYP/(6-311 + G(2df,p))//B3LYP/6-31G(d,p) level of theory. 
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Within the X-ray crystal structures it was noted that the threonyl moiety bidentatively ligates to the 
Zn(II) ion via both its Thr-NH2 and R-group hydroxyl. This substrate-bound active site complex was 
indeed found to be the lowest in energy (Figure 1). However, facilitated by a hydrogen bond between 
the R-group hydroxyl and the carboxylate of the nearby Asp383 residue, the Zn(II)···(H2)N-Thr 
interaction was calculated to quite readily cleave to give an only very slightly higher energy  
reactive complex (RC). Notably, in the latter complex the Thr-NH2 group hydrogen bonds to the 
Ado76-3'-OH moiety. 
Figure 1. The Michaelis complex model (PRC) used for QM-cluster calculations in ThrRS 
including a neutral His309. 
 
We then systematically examined the proposed catalytic mechanism as well as possible alternatives. 
Specifically, we first considered mechanisms by which His309-H+ may act as a catalytic acid. The 
lowest energy pathway was found to involve proton transfer from His309-H+ onto the Ado76-2'-OH 
group. The latter concomitantly transferred its own proton via active site water onto the Thr-AMP’s 
carbonyl oxygen. The overall barrier for this mechanism was calculated to be quite high at 
approximately 141.4 kJ mol−1. Meanwhile, no mechanistic pathway could be identified at the above 
level of theory in which a neutral His309 acts as a base to abstract a proton from the Ado76-2'-OH 
group as experimentally proposed [63,64]. 
However, as noted above, in the optimized structure of the RC complex involving a neutral His309, 
the substrate’s own Thr-NH2 group is hydrogen bonded to the Ado76-3'-OH moiety. That is, cleavage 
of the Zn(II)···(H2)N-Thr interaction allows the Thr-NH2 to re-position itself to accept the Ado76-3'-OH 
proton. Indeed, beginning from such an RC direct nucleophilic attack of the Ado76-3'-OH oxygen at 
the substrates carbonyl carbon centre occurs with a much lower barrier of only 105.1 kJ mol−1. 
Furthermore, this step proceeds with concomitant transfer of the Ado76-3'-OH proton onto the  
Thr-NH2 (i.e., forms Thr-NH3+) as shown in Scheme 5. The resulting tetrahedral oxyanion 
intermediate (IC1) was calculated to lay only 52.8 kJ mol−1 higher in energy than the reactive complex 
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RC. In the subsequent step, the Csubstrate–OP bond within the former aminoacyl-AMP moiety is cleaved 
with effectively no barrier. This gives the final product complex PC lying 15.8 kJ mol−1 lower in 
energy than RC, in which the threonyl moiety has now been transferred onto the Ado76-3'-oxygen. 
Thus, computationally, it is suggested that ThrRS also uses a substrate-assisted catalytic mechanism. 
Now, however, due in part to the presence of the Zn(II) and lability of the Zn(II)···(H2)N-Thr interaction, 
the -NH2 moiety is instead able to act as the required mechanistic base. 
Scheme 5. The overall computationally obtained mechanism for aminoacylation as 
catalyzed by threonyl-tRNA synthetase (see text). 
 
2.3. Substrate Specificity and Initial Mechanisms of S-ribosylhomocysteinase (LuxS) 
Conventionally, problems pertaining to enzymatic mechanisms can be placed into either one of two 
categories: specificity and rate-enhancement [66]. The former concerns itself with the ways in which 
substrates interact with enzymes’ binding site components, while the latter pertains to factors involved 
in the lowering of energy barriers including those that stabilize transition states and/or destabilize 
reactant/intermediates complexes. While these serve as separate conjectural models, they are in fact 
interdependent; insights into one can provide information on the other. 
S-Ribosylhomocysteinase (LuxS) is a non-heme iron-containing enzyme that plays a key role in 
type-2 quorum sensing (QS-2), an important intra-organism communication and regulation process 
that helps regulate gene expression and microbial cell population [17]. QS-2 has been suggested to act 
as a universal language amongst bacterial species. Due to its possible involvement in the spread of 
infections, it has been suggested as a potential target for inhibition and LuxS inhibitors in particular 
could serve as broad-spectrum antibiotics [67]. 
From a chemical perspective, LuxS catalyzes the conversion of S-ribosylhomocysteine (SRH) into 
homocysteine and 4,5-dihydroxy-2,3-pentadione (DPD). Interestingly, it cleaves a stable thioether 
bond and mediates an internal redox reaction without the help of any redox-active cofactors.  
Despite the many experimental studies investigating its mechanism [67–70], many key fundamental 
questions remain including the nature of the substrate when bound in the active site. More specifically, 
SRH can co-exist in solution in three forms: two cyclic (α- and β-) furanose-containing SRH anomers 
and a corresponding linear aldose form (linear-SRH). Each one has quite distinct functionality and/or 
stereochemistry and thus, given that enzymes are often highly stereospecific it is unknown if  
LuxS binds two or more of these forms. Consequently, how the enzymes LuxS could perform its 
catalytic function on two or more of these substrates is unknown. For instance, could it possibly 
proceed via a common intermediate (Scheme 6)? 
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Scheme 6. Schematic representation of the conjectured conversion of  
S-ribosylhomocysteine (α-SRH), β-SRH and linear-SRH into common putative  
2-keto mechanistic intermediate. 
 
By a synergetic application of docking, MD and QM/MM for each of the possible substrate isomers 
we investigated the nature of the substrate-bound active site and the possible initial mechanistic 
reaction steps [17]. LuxS···substrate complex models were generated starting from the X-ray crystal 
structure of a C84A Co(II)-substituted LuxS with a presumed 2-keto-ribose intermediate (2-keto-SRH) 
(PDB:1YCL). Co(II) was replaced with Fe(II) and the mutation was reversed to regenerate the  
wild-type active site. A LuxS···linear-SRH model was modeled using the 2-keto-SRH as template 
while α-SRH and β-SRH were docked in the active site. The resulting models were sequentially 
minimized using the AMBER99 molecular mechanics force field. During MD simulations, annealing 
and production stages were performed in conjunction with the AMBER99 forcefield for an overall 
duration of 5 ns. During production stages a constant temperature of 300 K was used and residues 
within 13.5 Å of the substrate were free to move. 
For both the α-SRH···LuxS and β-SRH···LuxS complexes the variation of the root-mean square 
deviations (RMSD) of the substrates’ atomic positions within the binding site in every snapshot during 
the course of the 5 ns simulation was analyzed, i.e., their degree of flexibility and consistency in 
positioning. Average structures obtained from clusters analyses over the simulations clearly indicated 
that both cyclic anomers maintained consistent active site-substrate associations over the course of the 
simulations. Specifically, the O2 and O3 ribosyl oxygens remained ligated to the Fe(II) centre 
throughout the MD with average distances no greater than 2.30 Å. Simultaneously, the ribosyl –O3H 
hydroxyl group maintained a hydrogen bond with the anionic carboxylate of a nearby active site 
glutamate (E57) residue with average distances of 2.52 Å or less. Meanwhile, the cysteinyl (C84)  
that has been suggested to be catalytically essential was found to be positioned near both substrates 
ribosyl –C2H– moiety; i.e., suitably positioned for proton abstraction as has been experimentally 
proposed [71]. The RMSD’s of the active site residues over the course of the 5 ns simulation were also 
considered and found to vary within a quite narrow range of approximately only 0.15–0.38 Å. That is, 
both cyclic possible substrates as well as the active site residues exhibit limited fluxional behavior with 
consistent positioning throughout the simulations. 
In contrast, the bound linear-SRH conformation was more dynamic; cluster analysis of the MD 
simulation and the corresponding calculated RMSD’s indicated that it alternates between two distinct 
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conformations. In the preferred conformation, with RMSD’s in the range of 0.35–0.55 Å, Cys84 was 
not positioned above the ribosyl C2H moiety. Furthermore, there are a reduced number of active site 
residue···linear-SRH interactions. Thus, while LuxS can bind all three SRH isoforms, the stability of the 
bound linear-SRH···LuxS complex is lower than that of both bound cyclic α-/β-SRH···LuxS complexes. 
Possible initial steps for the catalyzed interconversion of the cyclic- and linear-SRH forms were 
then considered using an ONIOM(QM/MM)-based methodology [17]. We first considered a ribosyl 
ring opening mechanism starting from bound α- and β-SRH in which the C1–OH proton transfers 
directly to the ring oxygen O4 to form the respective bound linear-SRH complexes. While in both 
cases this was a concerted mechanism, i.e., ring opening with proton transfer, the reaction barriers for 
α- and β-SRH ring opening processes were 207.6 and 155.6 kJ mol−1 respectively. Thus, such “direct” 
interconversion mechanisms are unlikely to be feasible. 
Experimentally, it had been suggested that LuxS may catalyze the ring opening [68]. Indeed, within 
all three MD obtained solvated structures of the bound active sites, a water molecule was ligated to the 
Fe(II) centre. For both α- and β-SRH, the Fe(II) acts as a Lewis acid, thereby increasing the acidity of 
coordinated ribosyl –O2H group. As a result, it is able to transfer its proton onto the active site water 
which concomitantly transfers a proton onto the ribosyl ring oxygen O4. Simultaneously for both 
anomers, the Cys84 thiolate deprotonates the ribosyl –C2H– moiety. Notably, for α- and β-SRH, this 
step occurs with barriers of 87.8 and 60.6 kJ mol−1 respectively (Figure 2); barriers that are 
enzymatically feasible. This step leads to the respective ring-opened intermediates α- and β-IC1 lying 
significantly lower in energy than their corresponding bound active site complexes α- and β-RC. 
Subsequently, for both α- and β-IC1, the now neutral thiol of Cys84 then transfers its –SH proton onto 
the intermediates C1 centre via α- and β-TS1 with barriers of 120.8 and 82.2 kJ mol−1, respectively 
(see Figure 1). It is noted that both of these transition structures are themselves markedly lower in 
energy than the lowest energy reactant complex α-RC. Remarkably, for both the α- and β-anomers this 
last step results in formation of a common intermediate, 2-keto-SRH that has been experimentally [72] 
shown to be a mechanistically viable intermediate. 
In the case of linear-SRH, the Fe(II) again ligates to the substrate via the latter 2-OH and 3-OH 
oxygens. As a result of this interaction the –O2H is able to readily act as an acid, transferring its proton 
onto the nearby C1=O oxygen. Concomitantly, the R-group thiolate of Cys84 abstracts a proton from 
the ribosyl –C2H– moiety. This reaction occurs with a barrier of just 6.4 kJ mol−1 and gives the 
intermediate α-IC1. Importantly, the latter was also encountered in the water-assisted ring opening 
mechanism for active site bound β-SRH [17]. 
The coupling of docking, MD and QM/MM methods proved to particularly insightful when 
examining substrate binding by LuxS and the subsequent initial reaction steps. As seen above, they 
reveal that LuxS can bind all three possible substrates—α-SRH, β-SRH and linear-SRH—with varying 
stability. Subsequent elucidation of possible catalytic mechanisms via the use of QM/MM showed how 
active site water may facilitate opening of the ribosyl-ring in α-SRH and β-SRH. Importantly, it also 
showed how LuxS may bind its S-ribosylhomocysteine substrate in any of its forms and then convert 
all to a common mechanistic intermediate 2-keto-SRH (IC2) as illustrated in Figure 2. 
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Figure 2. Potential energy profile for conversion of for α- and β-SRH into a 2-keto-SRH 
intermediate via a water-mediated ring opening process. The blue/red potential energy 
surface corresponds to the α/β-SRH conversion, respectively. The colored lines in the 
transition state schematic structures correspond to the particular bonds being broken  
and formed. 
  
2.4. MsrA and Its Reductive Ability: A Docking, MD and Multi-Model QM/MM Study 
Methionine sulfoxide reductases (Msr’s) are a ubiquitous class of antioxidant enzymes that reduce 
methionine sulfoxide (MetSO) to methionine. Msr’s are commonly divided into two subclasses, 
labeled as A and B, that have quite distinct active sites. Notably, however, they are stereospecific for 
the S- and R-epimers of MetSO, respectively [73]. Due in part to their antioxidant roles in protein 
biochemistry, they are believed to play key roles in aging and age related diseases [74–76]. Indeed, for 
several species it has been shown that the overexpression of MsrA increases their life span [77,78]. 
Regardless of the class and their active site differences, Msr’s are generally believed to utilize a 
common mechanism [79]. More specifically, it is believed that the mechanism starts with the 
activation of an active site cysteinyl residue, known as the catalytic cysteinyl (Cyscat), by an unknown 
base followed by a subsequent nucleophilic attack of Cyscat on the R-group sulfur center of methionine 
sulfoxide (MetSO). This results in the formation of a hypervalent sulfurane species in which Cyscat is 
now covalently linked with the MetSO sulfur [80]. This occurs concomitantly with protonation of the 
R-group MetSO S=O oxygen by an active site acid. For MsrA mutation of an active site glutamyl 
(Glu) to alanyl drastically reduced the rate of catalysis, suggesting a possible role in activating Cyscat [81]. 
However, X-ray crystal structures of MsrA generally show large distances between the R-groups Glu 
and Cyscat [82]. In addition, single mutation of either of the two MsrA active site tyrosyls to 
phenylalanyl had insignificant effects on catalysis, while their double mutation had drastic effects [81]. 
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Nevertheless, the sulfurane intermediate then undergoes further reaction to give methionine (Met) and 
a Cyscat derived sulfenic acid (CyscatSOH). 
The mechanism by which such a species is formed is much debated in the literature [73,83]. This is 
partly due to the fact that sulfenic acid is a highly reactive species and thus, does not lend itself to 
experimental characterization or even identification [84]. This renders the application of computational 
methods particularly useful. It had previously been suggested that the CyscatSOH sulfenic oxygen was 
obtained from the sulfoxide of MetSO. However, recent experimental studies have proposed that it is 
instead derived from the aqueous solvent [73]. Finally, a second active site cysteinyl, known as the 
recycling cysteine (CysRec), nucleophilically attacks the sulfur centre of CyscatSOH to give an 
intramolecular disulfide bond (CyscatS–SCysRec) and a water molecule. 
Through a complementary modeling approach, we recently investigated the catalytic mechanism of 
an MsrA from Mycobacterium tuberculosis [81]. An X-ray crystallographic structure of a complex of 
MsrA with a protein-bound methionine (PDB code: 1 NWA) was used as a template for further 
calculations [81]. In particular, due to a paucity of X-ray crystallographic information with regards to 
the actual enzyme-bound substrate MetSO, a thermally relaxed (at 298 K) solvated enzyme-substrate 
structure (i.e., potential Michaelis complexes) was obtained by first docking MetSO within MsrA. 
Then, the 30 top-scoring structures were minimized using an MM method with the “best” then 
subjected to solvation and thermal relaxation via appropriate 1 ns MD simulations [81]. 
Importantly, analysis of the structures encountered over the course of the MD simulations clearly 
indicated a consistent hydrogen bond bridge via a water molecule between the thiol of the recycling 
cysteinyl (Cys13) and the carboxylate of an active site glutamyl (Glu52) which has been proposed to 
be important [82]. This suggests that Glu52 may act indirectly (i.e., via a water) to activate the 
mechanistically key Cys13 residue. Furthermore, consistent strong hydrogen bonding interactions were 
observed between the substrate’s sulfoxide oxygen and the R-group phenols of two active site tyrosyl 
residues (Tyr44 and Tyr92). A suitable chemical model of the substrate-bound active site was derived 
from the average structure of the MD simulation [81] for use in the subsequent ONIOM (QM/MM) 
investigation on possible reaction steps leading to formation of an enzyme derived sulfenic acid  
(i.e., Cys13S-OH). More specifically, optimized structures, vibrational frequencies and Gibb’s free 
energy corrections (ΔGcor) were obtained at the ONIOM (B3LYP/6-31G(d):AMBER96) level of 
theory within a mechanical embedding (ME) formalism. Relative Gibb’s free energies were 
subsequently determined via single point calculations on the above structures at the ONIOM 
(B3LYP/6-311 + G(2df,p):AMBER96) level of theory within an electrostatic embedding (EE) 
formalism with inclusion of the appropriate ΔGcor. The latter use of EE allows one to better model the 
effects of the non-homogeneous protein environment surrounding the active site region. 
Notably, the QM/MM studies indicated that a substrate-bound pre-reactive complex (PRC) in which 
Cys13 was neutral (i.e., Cys13SH) and Glu52 anionic (i.e., Glu52COO−), could interconvert to a 
reactive complex (RC) in which Cys13 had been deprotonated (i.e., Cys13S−) by Glu52 at a free 
energy cost of 49.3 kJ mol−1 (Scheme 7). In the next step, the sulfur of Cys13S− nucleophilically 
attacks the sulfur of the MetSO substrate, with concomitant proton transfer from the now neutral 
Glu52COOH group onto the MetSO sulfoxide oxygen with a small barrier of only 11.8 kJ mol−1.  
The resulting sulfurane intermediate is predicted to lay almost thermoneutral with PRC, being  
47.0 kJ mol−1 lower in free energy than RC. As noted above, mutation of both Tyr44 and Tyr92 to Phe 
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significantly inhibited catalysis, in contrast to that observed for single mutation of either Tyr [82]. 
Notably, the sulfurane oxygen remains hydrogen bonded to both R-group –OH of Tyr44 and Tyr92. 
Indeed, either Tyr-OH group is then able to act as an acid. Specifically, they protonate the sulfurane 
oxygen, with essentially no reaction barrier, to give H2O and a sulfonium intermediate lying a further 
7.0 or 40.4 kJ mol−1 lower in energy depending on whether the proton was donated by Tyr92 or Tyr44, 
respectively. The thiol of the recycling cysteinyl (Cys154) is hydrogen bonded to a nearby carboxyl of 
Asp87. Furthermore, a water molecule was observed in the MD simulations and in the ONIOM studies 
to be consistently positioned near the Cys13 sulfur, and hydrogen bonded with the thiol of Cys154. 
Consequently, Cys154 is able to help activate the H2O for nucleophilic attack at the Cys13 sulfur of 
the sulfonium intermediate. This leads to formation of free Met, i.e., reduced MetSO, and a  
Cys13-derived sulfenic acid lying markedly lower in energy. That is, sulfenic acid formation is 
predicted to be a quite exergonic process. We also re-examined this process in which either Tyr92 or 
Tyr44 were mutated to a Phe residue. The reaction barriers did not change significantly, in agreement 
with experimental observations. 
Scheme 7. Schematic representation of the computationally proposed mechanism for the 
reduction of methionine sulfoxide via sulfenic acid to disulfide. 
 
In many computational studies, MD simulations are used solely to generate a suitable structure of 
the bound-substrate active site. However, the free Met is now able to leave the active site and this may 
lead to changes in the active site. Hence, we performed an MD simulation on the sulfenic acid 
intermediate as summarized above, and obtained a suitable chemical model of the sulfenic acid 
intermediate for investigation of its subsequent reduction using the above ONIOM-based approach. 
Furthermore, the new-modeled QM layer is now different from the previous one as we focused on 
including the surrounding residues of Cys154 to better elucidate the mechanism. The reaction of 
Cys13SOH to give an intramolecular Cys13S–SCys154 disulfide bond was determined to be able to 
occur via a multistep process. More specifically, Asp87 indirectly acts via bridging water to 
deprotonate the thiol of Cys145 (i.e., the recycling cysteinyl). The resulting complex, containing a now 
“activated” Cys154S− moiety, lies only 51.8 kJ mol−1 higher in energy than the lowest energy 
Cys13SOH-containing intermediate. The Cys154S− sulfur is then able to readily react with the 
Cys13SOH moiety with a barrier of only 39.4 kJ mol−1 to form the disulfide product (Figure 2).  
The reduction of the sulfenic acid is calculated to be a highly exergonic process with the disulfide 
product lying significantly lower in energy than the sulfenic acid intermediate complex [81]. 
Int. J. Mol. Sci. 2014, 15 417 
 
Thus, the complementary use of docking, molecular dynamics and ONIOM (QM/MM) 
computational chemistry methods provided several key insights into the overall mechanism of MsrA 
(Scheme 7), including the role of key active site residues such as Glu52, Tyr92 and Tyr44. In addition, 
it also suggested possible mechanistic roles for other active site residues such as Asp87. Furthermore, 
our results complement previous experimental mutagenesis studies. 
3. Conclusions 
This review presented a variety of examples pertaining to the use of distinguished computational 
methods in deciphering enzyme catalysis. As shown herein, DFT clusters, QM/MM, molecular 
docking and MD simulations can be used, either in their own right or as members of an assembly in 
the investigation of enzymatic processes. As seen, in the absence of a crystal structure and while the 
nature of the biocatalytic environment has not been experimentally resolved, QM-DFT clusters can 
model and compare an extensive set of possible reactive species. In the cases where crystal structures 
exist but essential details pertaining to the active site’s protonation state and substrate’s binding 
conformation remain elusive, docking, MD simulations and QM/MM can be combined in the 
framework of a single analysis. In the cases where an enzymatic process involves the exit of a 
substrate during catalysis, MD simulations can model the resulting conformational changes while the 
use of different QM/MM models can model the catalysis. The synergistic use of experimental  
chemical methods coupled with divergent multi-scale methods, ranging from the quantum- to the  
statistical-mechanical, holds promise in uncovering the key to enzymatic catalysis. 
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